Chen Fu, Jingcan Qin, Xinlong Liu, & Fei Kong. (2022). Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan-Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy. MDPI AG.
Chicago Style (17th ed.) CitationChen Fu, Jingcan Qin, Xinlong Liu, and Fei Kong. Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan-Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy. MDPI AG, 2022.
MLA (9th ed.) CitationChen Fu, et al. Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan-Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.